These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 162676)

  • 21. Clinical aspects of the treatment of obesity by drugs: a review.
    Munro JF
    Int J Obes; 1979; 3(2):171-80. PubMed ID: 393645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind trial of mazindol using a very low calorie formula diet.
    Baird IM; Howard AN
    Int J Obes; 1977; 1(3):271-8. PubMed ID: 363631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ephedrine as an anorectic: the story of the 'Elsinore pill'.
    Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F
    Int J Obes; 1981; 5(2):183-7. PubMed ID: 7228474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity.
    Arterburn D
    Clin Evid; 2004 Jun; (11):762-76. PubMed ID: 15652036
    [No Abstract]   [Full Text] [Related]  

  • 25. Anorectic drugs which stimulate thermogenesis.
    Lang SS; Danforth E; Lien EL
    Life Sci; 1983 Sep; 33(13):1269-75. PubMed ID: 6888178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of obesity. Appetite suppressant drugs and intestinal by-pass surgery.
    Bleehen SS; Edwards IR; Clark RG
    Br J Dermatol; 1976 Aug; 95(2):219-222. PubMed ID: 782507
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical and basic aspects of an anorexiant, mazindol, as an antiobesity agent in Japan.
    Inoue S; Egawa M; Satoh S; Saito M; Suzuki H; Kumahara Y; Abe M; Kumagai A; Goto Y; Shizume K
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):199S-202S. PubMed ID: 1728834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mazindol (AN-448): a new non-amphetamine anorectic in the treatment of exogenous obesity].
    Delitala G; Alagna S; Masala A
    Clin Ter; 1977 Jun; 81(6):547-54. PubMed ID: 884939
    [No Abstract]   [Full Text] [Related]  

  • 29. The current status of antiobesity drugs.
    Galloway SM; Farquhar DL; Munro JF
    Postgrad Med J; 1984; 60 Suppl 3():19-26. PubMed ID: 6393107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical use of mazindol in the treatment of essential obesity].
    Guazzelli R; Piazzini M; Conti C; Papi L; Strazzulla G; Matassi L
    Clin Ter; 1987 Mar; 120(5):385-91. PubMed ID: 2953538
    [No Abstract]   [Full Text] [Related]  

  • 31. A multicentre study comparing mazindol and placebo in obese patients.
    Walker BR; Ballard IM; Gold JA
    J Int Med Res; 1977; 5(2):85-90. PubMed ID: 326596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of mazindol, d-amphetamine and diethylpropion on purine nucleotide binding to brown adipose tissue.
    Lupien JR; Bray GA
    Pharmacol Biochem Behav; 1986 Oct; 25(4):733-8. PubMed ID: 3786335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of mazindol (teronac) on various hormonal indicators in children with simple obesity].
    Komorowski JM; Zwaigzne-Raczyńska J; Owczarczyk I; Gołebiowska M; Zarzycki J
    Pediatr Pol; 1982 Apr; 57(4):241-6. PubMed ID: 6755371
    [No Abstract]   [Full Text] [Related]  

  • 34. A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients.
    Follows OJ
    Br J Clin Pract; 1971 May; 25(5):236-8. PubMed ID: 4931755
    [No Abstract]   [Full Text] [Related]  

  • 35. Double-blind cross-over evaluation of mazindol in the treatment of obese hypertensive patients.
    Miach PJ; Thomson W; Doyle AE; Louis WJ
    Med J Aust; 1976 Sep; 2(10):378-80. PubMed ID: 792640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term and long-term clinical evaluation of a non-amphetaminic anorexiant (mazindol) in the treatment of obesity.
    Enzi G; Baritussio A; Marchiori E; Crepaldi G
    J Int Med Res; 1976; 4(5):305-18. PubMed ID: 1028632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative trial of fenfluramine and diethylpropion inbesity.
    Silverstone JT; Cooper RM; Begg RR
    Br J Clin Pract; 1970 Oct; 24(10):423-5. PubMed ID: 4923926
    [No Abstract]   [Full Text] [Related]  

  • 38. Diethylpropion hydrochloride: an effective appetite suppressant.
    Bolding OT
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):40-8. PubMed ID: 4203847
    [No Abstract]   [Full Text] [Related]  

  • 39. Dental considerations of patients taking appetite suppressants.
    Wynn RL
    Gen Dent; 1997; 45(4):324-8, 330-1. PubMed ID: 9515435
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of an anorectic agent (Mazindol) on control of obese diabetics.
    Sanders M; Breidahl H
    Med J Aust; 1976 Oct; 2(15):576-7. PubMed ID: 994969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.